What the attachments actually show

• WBC 23.7 x10^9/L (high) with Gran% 84.6% (high) and Lymph% 9.3% (low) - marked neutrophilic leukocytosis
• HGB 11.6 g/dL (low-normal, mild anemia), MCH 26.1 and MCHC 30.6 (both low - hypochromic picture)
• RDW-CV 17.3% (high) - anisocytosis
• PLT 273 (normal), MPV 11.2 (mildly high), PCT high

General framework: T2DM patient, HR 155, ECG done

Step 1 - Narrow vs wide QRS on the ECG decides everything

• Sinus tachycardia (usually 100-150, rarely sustains at 155 unless there is a strong driver - fever/sepsis, pain, anemia, hypovolemia, thyrotoxicosis, PE, anxiety, drugs/caffeine)
• Atrial fibrillation with rapid ventricular response - very common in a 55-year-old diabetic, especially with irregular R-R intervals and absent P waves
• Atrial flutter with variable/2:1 block
• Paroxysmal SVT (AVNRT/AVRT) - abrupt onset/offset, regular, often 150-220 bpm
• Multifocal atrial tachycardia - seen more in COPD but also in metabolic stress

Step 2 - Why T2DM matters specifically here

• Diabetics have a much higher prevalence of coronary artery disease and silent myocardial ischemia/infarction because autonomic neuropathy blunts anginal pain - a diabetic can be having an acute MI with tachycardia as the only clue, no chest pain.
• Diabetic autonomic neuropathy itself causes resting/postural sinus tachycardia independent of any acute event.
• Diabetics are at higher risk of atrial fibrillation (confirmed in recent meta-analyses) and of arrhythmia related to electrolyte disturbance from DKA/HHS or from medications (e.g., diuretics causing hypokalemia).
• Uncontrolled hyperglycemia with dehydration (HHS) or DKA (more T1DM but occurs in T2DM under stress) commonly presents with sinus tachycardia as a compensatory response to volume depletion.

Step 3 - Probable diagnoses, ranked by likelihood in a 55-year-old T2DM patient with HR 155

1. New-onset atrial fibrillation with rapid ventricular response - most common cardiac arrhythmia in this demographic
2. Sinus tachycardia secondary to a systemic driver - sepsis/infection, DKA/HHS, anemia, dehydration, thyrotoxicosis, pain/anxiety
3. Paroxysmal SVT (AVNRT) - if onset was abrupt and regular
4. Silent acute coronary syndrome presenting atypically as tachycardia/arrhythmia (must be actively excluded in any diabetic with unexplained tachycardia)
5. Ventricular tachycardia if QRS is wide - treat as cardiac emergency
6. Less common: PE, hyperthyroidism-precipitated AF, drug-induced (bronchodilators, decongestants, stimulants)

Step 4 - "Curative"/confirmatory work-up (this is a diagnostic work-up, not a single "curative test")

• 12-lead ECG (already done) - read for rate/rhythm regularity, P-wave morphology, QRS width, ST-T changes, QTc
• Troponin (high-sensitivity if available), CK-MB - to rule out silent MI
• Random/fasting blood glucose, HbA1c, serum ketones/blood gas - rule out DKA/HHS as the driver
• Serum electrolytes (K+, Mg2+, Ca2+), renal function - arrhythmia triggers
• CBC - infection, anemia (this is the only report you actually attached)
• TSH/free T4 - thyrotoxicosis is a classic reversible cause of sinus tach and new AF
• Echocardiogram - assess LV function, structural disease, valvular disease, wall motion abnormality if MI suspected
• Holter monitor/rhythm strip if the tachycardia is paroxysmal and not captured well on the single ECG
• D-dimer/CT pulmonary angiogram if PE is clinically suspected (tachypnea, hypoxia, risk factors)
• Blood/urine cultures + CRP/procalcitonin if the CBC pattern (like the leukocytosis in the report you sent) suggests sepsis

Step 5 - Treatment, in depth

• Assess hemodynamic stability - hypotension, altered mentation, chest pain, or pulmonary edema in the setting of tachycardia mean immediate synchronized cardioversion per ACLS, not medical therapy.
• IV access, oxygen if hypoxic, continuous cardiac monitoring.

• Vagal maneuvers first (Valsalva, carotid massage if no bruit/no carotid disease)
• IV adenosine 6 mg rapid push, repeat 12 mg if needed
• If recurrent/refractory: IV beta-blocker (metoprolol) or non-dihydropyridine calcium channel blocker (diltiazem) - use calcium channel blockers cautiously if there's any concern about LV dysfunction

• Rate control: IV beta-blocker or diltiazem (avoid CCBs if heart failure with reduced EF)
• Rhythm control/cardioversion if new-onset (<48h) and stable, or if unstable - cardiovert immediately
• Anticoagulation decision based on CHA2DS2-VASc - a 55-year-old with T2DM already scores at least 1 point for diabetes, so stroke-risk-based anticoagulation (DOAC preferred) needs to be addressed once rhythm is controlled
• Treat the underlying driver (thyroid, infection, electrolytes) in parallel

• Do NOT just rate-control with beta-blockers as first-line - treat the underlying cause (fluids for dehydration/DKA, antibiotics for sepsis, antipyretics for fever, correct anemia, treat thyrotoxicosis). Blunting compensatory sinus tachycardia pharmacologically without fixing the driver can be harmful (e.g., in sepsis or hypovolemia).

• Standard ACS pathway: aspirin, anticoagulation, consider dual antiplatelet therapy, urgent cardiology referral for possible angiography/PCI, statin, ACE inhibitor/ARB, beta-blocker once hemodynamically appropriate.
• Tight glycemic control (avoiding hypoglycemia) during the acute event, per current guidelines.

• Treat as VT until proven otherwise: amiodarone or synchronized cardioversion if unstable; identify and correct reversible causes (ischemia, electrolytes, QT-prolonging drugs); electrophysiology and ICD evaluation downstream if structural heart disease is confirmed.

• Optimize glycemic control (HbA1c target individualized, usually <7% in otherwise healthy 55-year-olds without hypoglycemia risk)
• SGLT2 inhibitors have shown reduced atrial fibrillation burden/incidence in diabetics in recent meta-analyses (2025 data - PMIDs 40058622, 40484246, 39875820), so they are a reasonable glucose-lowering choice in a diabetic who develops AF, on top of their cardiovascular benefit
• Address modifiable cardiovascular risk factors: BP control, lipid management, smoking cessation

Bottom line

1. Correlating all the data

2. Probable diagnosis

• Sepsis-driven sinus tachycardia (compensatory, not a primary arrhythmia)
• Reactive neutrophilic leukocytosis + markedly raised CRP/ESR
• Stress/decompensated hyperglycemia (RBS 420)
• Mild pre-renal azotemia (raised urea/creatinine, likely from dehydration + infection, with a possible underlying diabetic nephropathy component given the 2+ proteinuria)

• Diabetic ketoacidosis / HHS as a co-driver - RBS of 420 with tachycardia warrants checking blood/urine ketones and a venous blood gas, which were not done here.
• Silent myocardial ischemia - troponin is reassuring (negative) but CK-MB is mildly up; diabetics can have painless ischemia due to autonomic neuropathy, so a single negative troponin doesn't fully close this door.
• Possible pre-excitation (WPW) - the "short PR interval" flag on the ECG can reflect enhanced AV conduction from sympathetic drive (fever/sepsis/hyperglycemia) OR early pre-excitation; if it doesn't normalize once the fever/infection resolves, this needs a formal cardiology read of the actual tracing (not just the auto-interpretation) for a delta wave.

3. Confirmatory / "curative-guiding" tests to perform next

1. Urine culture and sensitivity - single most important missing test; confirms the organism and lets you target antibiotics instead of treating empirically
2. Blood cultures x2 - to rule out bacteremia given the degree of leukocytosis/CRP/ESR
3. Serum lactate - sepsis severity/prognosis marker
4. Venous blood gas + urine/blood ketones - given RBS 420, must exclude DKA
5. HbA1c - establishes baseline glycemic control over preceding 3 months
6. Repeat/serial troponin at 3-6 hours - the report itself flags that a single negative result doesn't exclude MI within the diagnostic window
7. Ultrasound of the kidneys/urinary tract (KUB/renal USG) - to look for hydronephrosis, renal/perinephric abscess, obstructing calculus, or papillary necrosis, especially since urea/creatinine are already up
8. 2D-echocardiography - to assess LV function/wall motion given the CK-MB rise and diabetic risk of silent structural disease
9. Chest X-ray - rule out a pulmonary source of sepsis/fever
10. Repeat serum potassium - 5.10 is borderline high with renal impairment; hyperkalemia itself can cause dangerous arrhythmias, so this must be trended closely, not just noted once

4. Treatment - in-depth analysis

• Draw cultures first, then start empirical broad-spectrum IV antibiotics covering common uropathogens (e.g., a third-generation cephalosporin like ceftriaxone, or piperacillin-tazobactam if more severe/complicated) and de-escalate once culture sensitivity is back
• IV crystalloid fluids to correct dehydration and support renal perfusion, titrated carefully given her cardiac tachycardia (avoid fluid overload)
• Continuous vital sign and cardiac monitoring; treat fever with antipyretics
• Reassess with qSOFA/SIRS criteria for escalation to ICU-level sepsis care if she deteriorates (hypotension, altered sensorium, worsening lactate)

• With RBS 420 and an acute infection, this is a "sick-day"/hospitalized diabetic scenario: switch from oral agents to insulin (IV infusion if unstable, or basal-bolus subcutaneous once stable) for tighter, safer control
• Hold metformin given the borderline-elevated creatinine/urea - continuing it risks lactic acidosis in the setting of renal compromise and acute illness
• Monitor glucose every 2-4 hours until stable, then transition back to an outpatient regimen once the infection resolves and renal function is confirmed stable
• The relationship here is bidirectional and well established: hyperglycemia impairs neutrophil chemotaxis and worsens infection outcomes, while the infection itself raises counter-regulatory hormones and worsens hyperglycemia - both must be treated together, not sequentially

• Serial urea/creatinine to track whether this is purely pre-renal (should improve with hydration and treating sepsis) or represents underlying diabetic nephropathy
• Avoid nephrotoxic drugs (NSAIDs, contrast if imaging is needed, adjust antibiotic dosing to renal function)
• Nephrology referral if creatinine continues to rise or if significant proteinuria persists after the acute illness resolves (2+ albumin on a spot urine could be transient from infection/fever, or could reflect diabetic nephropathy - needs re-check once well)

• The correct approach to sinus tachycardia driven by sepsis/fever/hyperglycemia is to treat the underlying cause, not to blunt it with beta-blockers or rate-control agents, which could be harmful if she is volume-depleted or septic
• Continue cardiac monitoring; repeat ECG after the fever/infection is controlled to confirm the tachycardia and short-PR finding resolve
• If tachycardia or the short-PR/pre-excitation pattern persists once she is afebrile and euglycemic, refer to cardiology for further evaluation (Holter, possible EP study)
• Serial CK-MB/troponin to ensure no evolving myocardial injury, given her diabetic status and the mildly elevated CK-MB

• Repeat CBC, CRP, ESR, RFT, and urine routine at 48-72 hours to confirm response to antibiotics
• HbA1c-guided long-term diabetes regimen adjustment once acute illness resolves
• Diabetes education reinforcing that recurrent UTIs and poor glycemic control feed each other - tighter home glucose control reduces future infection risk

Bottom line